Literature DB >> 10192336

Effects of altered gene order or orientation of the locus control region on human beta-globin gene expression in mice.

K Tanimoto1, Q Liu, J Bungert, J D Engel.   

Abstract

The five human beta-type-globin genes, epsilon, Ggamma, Agamma, delta and beta, are close together and are regulated by a locus control region (LCR) located at the 5' end of the locus. Here we investigate the functional consequences of this organization with respect to temporal regulation of the individual genes, by using recombination techniques to invert the order of either the genes or the LCR in vivo. Our analysis of transgenic mice bearing either normal or mutant transgenes leads to two new observations. First, the position of the epsilon-globin gene next to the LCR is mandatory for its expression during the yolk-sac stage of erythropoiesis. Second, LCR activity is orientation dependent, and so the LCR does not act as a simple enhancer to stimulate transcription of the globin genes. Thus, in the absence of any change in transgene integration position, transgene copy number, trans-acting factors or other resident genetic information, simple inversion of the human genes or the LCR fundamentally alters the transcription of beta-type globin genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10192336     DOI: 10.1038/18698

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  70 in total

Review 1.  Genetics of Angelman syndrome.

Authors:  Y Jiang; E Lev-Lehman; J Bressler; T F Tsai; A L Beaudet
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

2.  Structural and functional conservation at the boundaries of the chicken beta-globin domain.

Authors:  N Saitoh; A C Bell; F Recillas-Targa; A G West; M Simpson; M Pikaart; G Felsenfeld
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

3.  Intergenic transcription in the human beta-globin gene cluster.

Authors:  K E Plant; S J Routledge; N J Proudfoot
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

4.  Characterization of the human beta-globin downstream promoter region.

Authors:  Kelly M Leach; Karen F Vieira; Sung-Hae Lee Kang; Ara Aslanian; Martin Teichmann; Robert G Roeder; Jörg Bungert
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

5.  Mammalian linker-histone subtypes differentially affect gene expression in vivo.

Authors:  Raouf Alami; Yuhong Fan; Stephanie Pack; Timothy M Sonbuchner; Arnaud Besse; Qingcong Lin; John M Greally; Arthur I Skoultchi; Eric E Bouhassira
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

6.  The genomic arrangement of T cell receptor variable genes is a determinant of the developmental rearrangement pattern.

Authors:  Na Xiong; Jeanne E Baker; Chulho Kang; David H Raulet
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

Review 7.  The regulatory network controlling beta-globin gene switching.

Authors:  W Shen; D P Liu; C C Liang
Journal:  Mol Biol Rep       Date:  2001       Impact factor: 2.316

8.  Recruitment of transcription complexes to the beta-globin gene locus in vivo and in vitro.

Authors:  Karen F Vieira; Padraic P Levings; Meredith A Hill; Valerie J Crusselle; Sung-Hae Lee Kang; James Douglas Engel; Jörg Bungert
Journal:  J Biol Chem       Date:  2004-09-22       Impact factor: 5.157

9.  Long-term and efficient expression of human β-globin gene in a hematopoietic cell line using a new site-specific integrating non-viral system.

Authors:  K Dormiani; H Mir Mohammad Sadeghi; H Sadeghi-Aliabadi; K Ghaedi; M Forouzanfar; H Baharvand; M H Nasr-Esfahani
Journal:  Gene Ther       Date:  2015-04-01       Impact factor: 5.250

10.  Transcriptional interference among the murine beta-like globin genes.

Authors:  Xiao Hu; Susan Eszterhas; Nicolas Pallazzi; Eric E Bouhassira; Jennifer Fields; Osamu Tanabe; Scott A Gerber; Michael Bulger; James Douglas Engel; Mark Groudine; Steven Fiering
Journal:  Blood       Date:  2006-10-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.